Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 25, 2020
Certara has acquired a range of modeling and simulation technology assets from In Silico Biosciences.
read more
Thursday, October 13, 2016
Certara®, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced that Peking Union Medical College (PUMC) Hospital in Beijing, China, and Keio University in Tokyo...
read more
Thursday, October 07, 2021
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire Pinnacle 21, a leading provider of SaaS solutions for clinical data fitness, regulatory compliance and ...
read more
Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, and Veristat, LLC., a leading full service clinical research organization, today...
read more
Wednesday, December 30, 2020
Cerner announced an agreement to acquire Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment.
read more
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Findings from this research are vital to NIAID’s efforts to advance vaccines, drugs, and ...
read more
Cerba Research, a leading global clinical trial laboratory services organization owned by Cerba HealthCare, announced today that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan ...
read more
Thursday, December 16, 2021
Viroclinics-DDL, employing a total of over 390 scientists and experts, offers a broad range of virology related services in the field of non-clinical and clinical trials, clinical diagnostics, assay development and clinical trial logistics enabling ...
read more
Wednesday, March 07, 2018
Themis Bioscience and CEPI have announced a partnership under which Themis will provide advanced vaccine development and manufacturing for Lassa fever and MERS.
read more
Thursday, February 05, 2026
The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics announced a partnership to strengthen vaccine manufacturing preparedness for future epidemic and pandemic threats.
read more
Cepheid has announced an agreement with Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., for the distribution of its GeneXpert® System and menu of 17 Xpert® tests spanning healthcare associated infections, critical infectious ...
read more
Veratrak has announced that CPO Central Pharma has selected its platform to help it achieve digitized end-to-end visibility of its supply chain and improve collaboration.
read more
Global contract packaging organization (CPO), Central Pharma, has partnered with Supply Chain Wizard to transform its digital operations.
read more
CENTOGENE announced a joint solution for the successful fight against the effects of SARS-CoV-2 - the virus causing COVID-19 - on the economy and social life in Germany.
read more
Centogene announced they will collaborate exclusively to initiate the Real-life data and Innovative Bioinformatic Algorithms (RIBA) project – starting with Epilepsy as the first indication.
read more